Acorah Software Products - Accounts Production 19.1.200 false true false true No description of principal activity 21 October 2024 31 October 2025 31 October 2025 16030077 Dr Chinedu IKE-MORRIS iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 16030077 2024-10-20 16030077 2025-10-31 16030077 2024-10-21 2025-10-31 16030077 frs-core:CurrentFinancialInstruments 2025-10-31 16030077 frs-bus:PrivateLimitedCompanyLtd 2024-10-21 2025-10-31 16030077 frs-bus:FilletedAccounts 2024-10-21 2025-10-31 16030077 frs-bus:Micro-entities 2024-10-21 2025-10-31 16030077 frs-bus:AuditExempt-NoAccountantsReport 2024-10-21 2025-10-31 16030077 frs-bus:Director1 2024-10-21 2025-10-31
Registered number: 16030077
Salus Gp Consulting Ltd
Unaudited Financial Statements
For the Period 21 October 2024 to 31 October 2025
Rizco Ltd
Salus Gp Consulting Ltd
Balance Sheet
As At 31 October 2025
Balance Sheet
Registered number: 16030077

| 31 October 2025
--- | ---
|  | £
Current assets |  | 4,108
Creditors: Amounts Falling Due Within One Year |  | (3,944 )
NET CURRENT ASSETS |  | 164
TOTAL ASSETS LESS CURRENT LIABILITIES |  | 164
NET ASSETS |  | 164
CAPITAL AND RESERVES |  | 164

## Notes

1. General Information
Salus Gp Consulting Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 16030077 . The registered office is 20 Wenlock Road, London, N1 7GU.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board

Dr Chinedu IKE-MORRIS Director
01/07/2026